Related Experiment Video
Updated: May 17, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Organosilicon molecules with medicinal applications.
Annaliese K Franz1, Sean O Wilson
1Department of Chemistry, University of California-Davis , One Shields Avenue, Davis, California, USA. akfranz@ucdavis.edu
Journal of Medicinal Chemistry
|October 16, 2012
Summary
Organosilicon small molecules offer unique medicinal potential due to their distinct chemical properties, enhancing drug potency and pharmacological attributes for various applications.
Area of Science:
- Medicinal Chemistry
- Organosilicon Chemistry
- Drug Discovery
Background:
- Organosilicon compounds possess unique chemical properties.
- These properties can be leveraged to improve drug efficacy and pharmacological profiles.
- Biological investigation of these molecules is a growing area of interest.
Purpose of the Study:
- To explore the medicinal applications of organosilicon small molecules.
- To highlight the advantages of incorporating silicon into drug design.
- To discuss current and potential uses in pharmaceutical research.
Main Methods:
- Review of existing literature on organosilicon compounds in medicinal chemistry.
- Analysis of structure-activity relationships for organosilicon-based drugs.
- Discussion of synthetic strategies for organosilicon small molecules.
Main Results:
- Organosilicon molecules demonstrate potential for enhanced potency and improved pharmacokinetic properties.
- Unique chemical characteristics of silicon enable novel therapeutic strategies.
- Diverse applications identified, including inhibitor design and advanced drug delivery.
Conclusions:
- Organosilicon small molecules represent a promising frontier in medicinal chemistry.
- Further research into their synthesis and biological evaluation is warranted.
- These compounds offer significant opportunities for developing next-generation therapeutics.
Related Concept Videos
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Properties of Organometallic Compounds
Organometallic compounds are compounds that contain a carbon–metal bond. Carbon belongs to an organyl group like alkyl, aryl, allyl, or benzyl groups. The metal can be from Group I or Group II of the periodic table, a transition metal, or a semimetal.

